CN115806498A - Method for synthesizing 5-chloroacetamide-2, 4, 6-triiodo-isophthaloyl chloride - Google Patents

Method for synthesizing 5-chloroacetamide-2, 4, 6-triiodo-isophthaloyl chloride Download PDF

Info

Publication number
CN115806498A
CN115806498A CN202111112694.4A CN202111112694A CN115806498A CN 115806498 A CN115806498 A CN 115806498A CN 202111112694 A CN202111112694 A CN 202111112694A CN 115806498 A CN115806498 A CN 115806498A
Authority
CN
China
Prior art keywords
chloride
triiodo
amino
solvent
chloroacetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111112694.4A
Other languages
Chinese (zh)
Inventor
吴渊
孟令桥
周英
周华明
石创业
朱小雷
王国苍
陈雪飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DDLD (BEIJING) PHARMACEUTICAL TECHNOLOGY CO LTD
Original Assignee
DDLD (BEIJING) PHARMACEUTICAL TECHNOLOGY CO LTD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DDLD (BEIJING) PHARMACEUTICAL TECHNOLOGY CO LTD filed Critical DDLD (BEIJING) PHARMACEUTICAL TECHNOLOGY CO LTD
Priority to CN202111112694.4A priority Critical patent/CN115806498A/en
Publication of CN115806498A publication Critical patent/CN115806498A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/584Recycling of catalysts

Landscapes

  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a method for synthesizing 5-chloroacetamide-2, 4, 6-triiodo isophthaloyl dichloride, which comprises the following steps: 5-amino-2, 4, 6-triiodo isophthalic acid chloride is used as a raw material, a nonpolar solvent is used as a solvent, and a phase transfer catalyst is used as a catalyst; heating and raising the temperature, and carrying out a condensation reaction on the 5-amino-2, 4, 6-triiodo isophthalic acid chloride and chloroacetyl chloride under the catalytic action of a phase transfer catalyst; after the condensation reaction is finished, cooling to room temperature, adding purified water into the system for crystallization, and filtering and drying to obtain the 5-chloroacetamido-2, 4, 6-triiodo isophthaloyl chloride. The method adopts toluene or xylene as a solvent, the yield of the prepared 5-chloroacetamide-2, 4, 6-triiodo isophthaloyl dichloride is more than 90 percent, the operation is simple, the used solvent of toluene or xylene can be recycled, and the waste water amount is small and easy to treat.

Description

Method for synthesizing 5-chloroacetamide-2, 4, 6-triiodo-isophthaloyl chloride
Technical Field
The invention relates to a synthesis method of 5-chloroacetamide-2, 4, 6-triiodo-isophthaloyl chloride, belonging to the technical field of chemical synthesis.
Background
5-chloroacetamide-2, 4, 6-triiodoisophthaloyl chloride is an important medical intermediate, and is mainly used for synthesizing a contrast agent ioversol and the like.
2,4, 6-triiodoisophthaloyl chloride is usually condensed with chloroacetyl chloride in solvents of N, N-dimethylformamide and N, N-dimethylacetamide, the reaction solution is viscous in the reaction process, the post-treatment needs to be carried out by adding the reaction solution into purification, and the product is precipitated at low temperature. The product yield after post-treatment is low, the used solvent can not be recovered, the waste water contains a large amount of nitrogen-containing compounds, and the environmental pollution is serious.
Patent CN101654417 reports that 5-amino-2,4,6-triiodo isophthalic acid chloride is used as raw material, N-dimethylacetamide is used as solvent, chloroacetyl chloride is added at low temperature, then the mixture is heated to 30-70 ℃ for reaction, after the reaction is finished, the reaction solution is added into ice water, crystallized at 5 ℃, and filtered to obtain the product, and the method is difficult in waste water treatment. US4396598A, US5648536 and US5075502A report similar and identical processes for the preparation of similar compounds using N, N-dimethylacetamide as solvent.
The ioversol injection is used for large-dose administration, 1ml contains 0.32 g of iodine, and the ioversol injection is sold in the market with the specifications of 20ml and 50ml, and the common dosage is 20-50 ml. Therefore, the consumption of raw materials of ioversol is huge, the preparation demand of the intermediate 5-chloroacetamide-2, 4, 6-triiodo-isophthaloyl dichloride is more, and the 5-chloroacetamide-2, 4, 6-triiodo-isophthaloyl dichloride prepared by taking N, N-dimethylacetamide as a solvent generates a large amount of nitrogen, thereby causing great pollution to the environment.
Disclosure of Invention
The invention aims to solve the technical problem of the prior art and provides a method for synthesizing 5-chloroacetamide-2, 4, 6-triiodo-isophthaloyl dichloride, which takes a nonpolar solvent as a solvent, adds a phase transfer catalyst, heats up, cools down, and then adds purified water for crystallization to obtain the 5-chloroacetamide-2, 4, 6-triiodo-isophthaloyl dichloride. The method for preparing the 5-chloroacetamide-2, 4, 6-triiodoisophthaloyl chloride has the advantages of simple operation, recoverable solvent, low cost and small environmental pollution.
In order to achieve the purpose, the invention adopts the following technical scheme:
a method for synthesizing 5-chloroacetamide-2, 4, 6-triiodo-isophthaloyl chloride comprises the following steps:
5-amino-2, 4, 6-triiodo isophthaloyl chloride is used as a raw material, a nonpolar solvent is used as a solvent, and a phase transfer catalyst is used as a catalyst; heating and raising the temperature, and carrying out a condensation reaction on the 5-amino-2, 4, 6-triiodo isophthalic acid chloride and chloroacetyl chloride under the catalytic action of a phase transfer catalyst; after the condensation reaction is finished, cooling to room temperature, then adding purified water into the system for crystallization, and obtaining the 5-chloroacetamide-2, 4, 6-triiodo isophthaloyl chloride after filtration and drying.
In the technical scheme, the molar ratio of the chloracetyl chloride to the 5-amino-2, 4, 6-triiodoisophthaloyl dichloride is 1: 1.0-2.0, preferably 1: 1.4-1.7.
In the technical scheme, the nonpolar solvent is any one of toluene and xylene or a mixture of the toluene and the xylene which are mixed in any proportion; preferably, the solvent is either toluene or xylene.
In the technical scheme, the mass ratio of the nonpolar solvent to the 5-amino-2, 4, 6-triiodo isophthaloyl chloride is 1: 1-3, preferably 1: 1.5-2.
In the technical scheme, the phase transfer catalyst is a mixture formed by mixing any one, two or more than two of tetrabutylammonium bromide, tetrabutylammonium chloride, tetrabutylammonium iodide, methyl trioctyl ammonium chloride, propylene glycol, DMF and DMAC in any proportion; preferably, the mixture is prepared by mixing any one, two or more than two of tetrabutylammonium bromide, methyltrioctylammonium chloride, DMF and DMAC in any proportion.
In the technical scheme, the mass ratio of the phase transfer catalyst to the 5-amino-2, 4, 6-triiodo isophthaloyl chloride is 1: 0.01-0.1, preferably 1: 0.02-0.05.
In the technical scheme, the condensation reaction is carried out at the reaction temperature of 60-90 ℃ for 6-12 h; preferably, the reaction temperature is 70-80 ℃, and the reaction time is 7-10 h.
In the technical scheme, the mass ratio of the purified water to the 5-amino-2, 4, 6-triiodo isophthaloyl chloride is 1: 0-2, preferably 1: 0.5-1.5.
In the technical scheme, the drying is carried out at the temperature of 50-60 ℃ for 8-10h.
The technical scheme of the invention has the advantages that: the invention adopts toluene or xylene as solvent, 5-amino-2, 4, 6-triiodo isophthalic acid chloride and chloroacetyl chloride react for condensation reaction under the action of phase transfer catalyst, the yield of 5-chloroacetamide-2, 4, 6-triiodo isophthalic acid chloride is more than 90% by post-treatment, cooling and adding purified water, the operation is simple, the used solvent toluene or xylene can be recovered, the waste water amount is small, and the treatment is easy.
Detailed Description
The following detailed description of the embodiments of the present invention is provided, but the present invention is not limited to the following descriptions:
the invention will now be illustrated with reference to specific examples:
example 1:
a method for synthesizing 5-chloroacetamide-2, 4, 6-triiodoisophthaloyl chloride comprises the following steps:
adding 5-amino-2, 4, 6-triiodoisophthaloyl chloride (200g, 0.34mol) into a 2L three-necked flask, adding 300g of toluene, adding 5g of methyl trioctylmethylammonium chloride, and adding 10g of DMAC; adding chloroacetyl chloride (56.87g, 0.50mol), heating to 70-80 ℃ after adding, keeping the temperature for 8h, monitoring 5-amino-2, 4, 6-triiodo isophthaloyl chloride by TLC for complete reaction, cooling to room temperature, adding 200g of purified water, stirring for 0.5h, filtering, and drying at 50-60 ℃ for 8h to obtain 210.3g of 5-chloroacetamido-2, 4, 6-triiodo isophthaloyl chloride with the yield of 93.2%, and the HPLC purity: 98.2 percent.
Example 2:
a method for synthesizing 5-chloroacetamide-2, 4, 6-triiodoisophthaloyl chloride comprises the following steps:
adding 5-amino-2, 4, 6-triiodoisophthaloyl chloride (200g, 0.34mol), adding 300g of dimethylbenzene, adding 5g of tetrabutylammonium bromide, adding 56.87g,0.50mol of chloroacetyl chloride, heating to 70-80 ℃ after adding, preserving heat for 10h, monitoring 5-amino-2, 4, 6-triiodoisophthaloyl chloride by TLC to react completely, cooling to room temperature, adding 100g of purified water, stirring for 0.5h, filtering, drying at 50-60 ℃ for 9h to obtain 206.5g of 5-chloroacetamido-2, 4, 6-triiodoisophthaloyl chloride, the yield is 91.5%, and the HPLC purity is as follows: 98.3 percent.
Example 3:
a method for synthesizing 5-chloroacetamide-2, 4, 6-triiodoisophthaloyl chloride comprises the following steps:
adding 5-amino-2, 4, 6-triiodo isophthaloyl chloride (300g, 0.504mol) into a 2L three-necked bottle, adding 450g of methylbenzene, adding 7.5g of tetrabutylammonium bromide and adding 15g of DMF; adding chloroacetyl chloride (91g, 0.81mol), heating to 70-80 ℃ after adding, keeping the temperature for 8h, monitoring the 5-amino-2, 4, 6-triiodo isophthaloyl chloride to be reacted completely by TLC, cooling to room temperature, adding 150g of purified water, stirring for 0.5h, filtering, drying at 50-60 ℃ for 10h to obtain 311.4g of 5-chloroacetamido-2, 4, 6-triiodo isophthaloyl chloride, the yield is 92.0 percent, and the HPLC purity is as follows: 97.8 percent.
Comparative example 1: DMAC as solvent
In a 1L three-necked flask, 5-amino-2, 4, 6-triiodoisophthaloyl chloride (60g, 0.1mol) was added to 125ml of N, N-dimethylacetamide at room temperature, stirred well, and cooled to 10 ℃. Dropping 16.0g (15 mmol) of chloroacetyl chloride for about 30min, heating to 50 ℃ after the addition, stirring for 4 hours, finishing TLC reaction, cooling to room temperature, dropping the reaction solution into 500ml of ice-water mixture, continuously cooling to 0-5 ℃, stirring for 1 hour, filtering, washing with 100ml of purified water, drying at 50-6 ℃ to obtain 57.1g of product, wherein the yield is 89%, and the HPLC purity: 96.1 percent.
The above examples are only for illustrating the technical concept and features of the present invention, and are not intended to limit the scope of the present invention. All equivalent changes or modifications made according to the spirit of the present invention should be covered within the protection scope of the present invention.

Claims (9)

1. A method for synthesizing 5-chloroacetamide-2, 4, 6-triiodo isophthaloyl chloride is characterized by comprising the following steps:
5-amino-2, 4, 6-triiodo isophthalic acid chloride is used as a raw material, a nonpolar solvent is used as a solvent, and a phase transfer catalyst is used as a catalyst; heating and raising the temperature, and carrying out a condensation reaction on the 5-amino-2, 4, 6-triiodo-isophthaloyl dichloride and chloroacetyl chloride under the catalytic action of a phase transfer catalyst; after the condensation reaction is finished, cooling to room temperature, adding purified water into the system for crystallization, and filtering and drying to obtain the 5-chloroacetamido-2, 4, 6-triiodo isophthaloyl chloride.
2. The synthesis method of claim 1, wherein the molar ratio of chloroacetyl chloride to 5-amino-2, 4, 6-triiodoisophthaloyl chloride is 1: 1.0-2.0.
3. The method according to claim 1, wherein the nonpolar solvent is one of toluene and xylene, or a mixture of toluene and xylene mixed at an arbitrary ratio.
4. The method as set forth in claim 1, wherein the mass ratio of the nonpolar solvent to the 5-amino-2, 4, 6-triiodoisophthaloyl chloride is 1: 1-3.
5. The synthesis method of claim 1, wherein the phase transfer catalyst is a mixture of one, two or more of tetrabutylammonium bromide, tetrabutylammonium chloride, tetrabutylammonium iodide, methyltrioctylammonium chloride, propylene glycol, DMF and DMAC in any proportion.
6. The synthesis method of claim 1, wherein the mass ratio of the phase transfer catalyst to the 5-amino-2, 4, 6-triiodoisophthaloyl chloride is 1: 0.01-0.1.
7. The synthesis method according to claim 1, wherein the condensation reaction is carried out at a temperature of 60-90 ℃ for 6-12 h.
8. The synthesis method according to claim 1, wherein the mass ratio of the purified water to the 5-amino-2, 4, 6-triiodoisophthaloyl chloride is 1: 0-2.
9. The synthesis process as claimed in claim 1, wherein the drying is carried out at 50-60 ℃ for 8-10h.
CN202111112694.4A 2021-09-15 2021-09-15 Method for synthesizing 5-chloroacetamide-2, 4, 6-triiodo-isophthaloyl chloride Pending CN115806498A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111112694.4A CN115806498A (en) 2021-09-15 2021-09-15 Method for synthesizing 5-chloroacetamide-2, 4, 6-triiodo-isophthaloyl chloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111112694.4A CN115806498A (en) 2021-09-15 2021-09-15 Method for synthesizing 5-chloroacetamide-2, 4, 6-triiodo-isophthaloyl chloride

Publications (1)

Publication Number Publication Date
CN115806498A true CN115806498A (en) 2023-03-17

Family

ID=85482305

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111112694.4A Pending CN115806498A (en) 2021-09-15 2021-09-15 Method for synthesizing 5-chloroacetamide-2, 4, 6-triiodo-isophthaloyl chloride

Country Status (1)

Country Link
CN (1) CN115806498A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283381A (en) * 1979-07-12 1981-08-11 Schering Aktiengesellschaft Triiodinated aminoacetamido isophthalamide x-ray contrast agents
ES2037605A1 (en) * 1991-11-18 1993-06-16 Invest Justesa Imagen S A Cent New iodinated dimers X=ray contrast agent prepn.
EP0571593A1 (en) * 1991-11-18 1993-12-01 Invest Justesa Imagen S A Cent New non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them.
CN101654417A (en) * 2009-09-01 2010-02-24 江苏省原子医学研究所 Preparation method of X-ray contrast agent ioversol intermediate

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283381A (en) * 1979-07-12 1981-08-11 Schering Aktiengesellschaft Triiodinated aminoacetamido isophthalamide x-ray contrast agents
ES2037605A1 (en) * 1991-11-18 1993-06-16 Invest Justesa Imagen S A Cent New iodinated dimers X=ray contrast agent prepn.
EP0571593A1 (en) * 1991-11-18 1993-12-01 Invest Justesa Imagen S A Cent New non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them.
CN101654417A (en) * 2009-09-01 2010-02-24 江苏省原子医学研究所 Preparation method of X-ray contrast agent ioversol intermediate

Similar Documents

Publication Publication Date Title
CN113354575B (en) Synthesis method of terbinafine
CN103524551B (en) Continuous production process of N-normal-butyl thiophosphoryl triamide
KR101764477B1 (en) Method for producing polyalkylene glycol derivative having amino group at end, with narrow molecular weight distribution
US20240109835A1 (en) Method for preparing 3,3'-diaminobenzidine
CN105198718A (en) Preparation method for buparvaquone
CN115806498A (en) Method for synthesizing 5-chloroacetamide-2, 4, 6-triiodo-isophthaloyl chloride
CN115448914A (en) Xanthone derivative, preparation method thereof and nitrile benzoxazine derivative containing xanthone structure
CN1986518A (en) Preparing process of 4,4-dinitro diphenyl ether
CN111187240B (en) Preparation method of 4, 4-diphenyl ether dianhydride
CN100368389C (en) Method for preparing hexafluoropropane
JPS5949217B2 (en) Method for producing substituted diphenyl ether
CN108689821B (en) Method for regenerating chloranil by oxidizing hydrogen peroxide
CN112279938A (en) Preparation method of sugammadex drug intermediate
CN1583752A (en) Synthesis of benzoxazole
CN110698421A (en) Synthesis method of benzoxazolone
CN100400525C (en) Process for the preparation of n-glycidylamines
JPH03176484A (en) Bicyclohexyltetracarboxylic acid compound and its anhydride
CN100506778C (en) Crystal pelleting and purifying method of aromatic carboxylic acid products
CN110156917B (en) Method for preparing sugammadex sodium by applying polymer-loaded trivalent phosphine compound
CN114349660B (en) Synthesis method of o-chlorobenzonitrile
CN114163366B (en) Preparation method of 4,4' -diamino diphenyl sulfone
CN102295591A (en) Novel preparation method of 4, 4-dichlorodiphenyl sulfone
JPS5910652B2 (en) Fluorine-containing phenylbenzoate compounds and their uses
WO2024000849A1 (en) Method for synthesizing caprolactam by means of beckmann rearrangement reaction
CN108046977A (en) A kind of method of selectivity production dichloro-p-xylene

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination